Patrick Joseph Arena

Patrick Joseph Arena

Auto-generated profile, based on publicly available information

Patrick Joseph Arena

Pfizer Inc

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2024 in Journal of Comparative Effectiveness Research
Verified
Journal Article
Open access
NLNatalie S Levy
Natalie S Levy
PAPatrick J Arena
Patrick J Arena
TJThomas Jemielita
Thomas Jemielita
SMShahrul Mt-Isa
Shahrul Mt-Isa
SMShane McElwee
Shane McElwee
GHGleicy M Hair
Gleicy M Hair
Aim: To evaluate how transportability methods are currently used for real-world evidence (RWE) generation to inform good practices and support adoption and acceptance of these methods in the RWE context. Methods: We conducted a targeted literature review to identify studies that transported an effect estimate of the clinical effectiveness or safety of a biomedical exposure to a target real-world population. Records were identified from PubMed-indexed articles published any time before 25 July 2023 (inclusive). Two reviewers screened abstracts/titles and reviewed the full text of candidate studies to identify the final set of articles. Data on the therapeutic area, exposure(s), outcome(s), original and target populations and details of the transportability analysis (e.g., analytic method used, estimate transported, stated assumptions) were abstracted from each article. Results: Of 458 unique records identified, six were retained in the final review. Articles were published during 2021–2023, focused on the US/Canada context, and covered a range of therapeutic areas. Four studies transported an RCT effect estimate, while two transported effect estimates derived from real-world data. Almost all articles used weighting methods to transport estimates. Two studies discussed all transportability assumptions, and one evaluated the likelihood of meeting all assumptions and the impact of potential violations. Conclusion: The use of transportability methods for RWE generation is an emerging and promising area of research to address evidence gaps in settings with limited data and infrastructure. More transparent and rigorous reporting of methods, assumptions and limitations may increase the use and acceptability of transportability for producing robust evidence on treatment effectiveness and safety.

1 April 2020 in Vaccine
Verified
Journal Article
Closed access
KHKui Huang
Kui Huang
STSha Tao
Sha Tao
XZXiaofeng Zhou
Xiaofeng Zhou
JMJingping Mo
Jingping Mo
BZBowen Zhu
Bowen Zhu
NHNa He
Na He

1 August 2020 in eClinicalMedicine
Verified
Journal Article
Open access
PAPatrick J. Arena
Patrick J. Arena
Monica MaltaMonica Malta
Monica Malta
ARAnne W. Rimoin
Anne W. Rimoin
SSSteffanie A. Strathdee
Steffanie A. Strathdee

13 May 2022 in Vaccine
Verified
Journal Article
Open access
AGAdva Gadoth
Adva Gadoth
DNDalau Mukadi Nkamba
Dalau Mukadi Nkamba
PAPatrick J. Arena
Patrick J. Arena
NHNicole A Hoff
Nicole A Hoff
CDCamille Dzogang
Camille Dzogang
ARAnne W Rimoin
Anne W Rimoin
Since the establishment of the Global Alignment of Immunization Safety Assessment in pregnancy (GAIA) case definitions in 2015, there has been an urgent need for field validation of pharmacovigilance feasibility in low- and middle-income countries. In this study, we assess the availability and quality of archival medical records at ten randomly selected high-traffic maternity wards in Kinshasa province, Democratic Republic of Congo (DRC). A retrospective cohort of mother-child pairs was established from all recorded births taking place at study sites between July 1, 2019 to February 28, 2020 through digitization of medical records. Adverse birth outcomes and maternal vaccination status, where available and linkable, were defined according to GAIA. Basic demographic information on mothers and newborns was also tabulated; birth outcomes were assessed for both intra-site prevalence and a pooled prevalence. A total of 7,697 mother-newborn pair records were extracted, with 37% of infants screening positive as cases of adverse outcomes. Maternal vaccination information was linkable to 67% of those cases. In total, 51% of stillbirths, 98% of preterm births, 100% of low birthweight infants, 90% of small for gestational age infants, 100% of microcephalic infants, and 0% of neonatal bloodstream infections were classifiable according to GAIA standards following initial screening. Forty percent of case mothers had some indication of tetanus vaccination prior to delivery in their medical records, but only 26% of case mothers met some level of GAIA definition for maternal vaccination during the pregnancy of interest. Archival birth records from delivery centers can be feasibly utilized to screen for stillbirth and maternal tetanus vaccination, and to accurately classify preterm birth, low birthweight, small for gestational age, and congenital microcephaly. Assessment of other neonatal outcomes were limited by inconsistent postpartum infant follow-up and records keeping.

21 October 2025 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PAPatrick J. Arena
Patrick J. Arena
YSYezhou Sun
Yezhou Sun
AJAshley Jaksa
Ashley Jaksa
YKYu‐Han Kao
Yu‐Han Kao
LYLara Yoon
Lara Yoon
VTVladimir Turzhitsky
Vladimir Turzhitsky

16 January 2023 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
PAPatrick J. Arena
Patrick J. Arena
CDCamille Dzogang
Camille Dzogang
AGAdva Gadoth
Adva Gadoth
DNDalau Mukadi Nkamba
Dalau Mukadi Nkamba
NHNicole A. Hoff
Nicole A. Hoff
ARAnne W. Rimoin
Anne W. Rimoin
Background: Little research has been conducted on the impact of the coronavirus disease 2019 (COVID-19) pandemic on either birth outcomes or the ability of archival medical records to accurately capture these outcomes. Our study objective is thus to compare the prevalence of preterm birth, stillbirth, low birth weight (LBW), small for gestational age (SGA), congenital microcephaly, and neonatal bloodstream infection (NBSI) before and during the first wave of the COVID-19 pandemic in Kinshasa, Democratic Republic of Congo (DRC). Methods: We conducted a facility-based retrospective cohort study in which identified cases of birth outcomes were tabulated at initial screening and subcategorized according to level of diagnostic certainty using Global Alignment of Immunization Safety Assessment in pregnancy (GAIA) definitions. Documentation of any birth complications, delivery type, and maternal vaccination history were also evaluated. The prevalence of each birth outcome was compared in the pre-COVID-19 (i.e., July 2019 to February 2020) and intra-COVID-19 (i.e., March to August 2020) periods via two-sample z-test for equality of proportions. Results: In total, 14,300 birth records were abstracted. Adverse birth outcomes were identified among 22.0% and 14.3% of pregnancies in the pre-COVID-19 and intra-COVID-19 periods, respectively. For stillbirth, LBW, SGA, microcephaly, and NBSI, prevalence estimates were similar across study periods. However, the prevalence of preterm birth in the intra-COVID-19 period was significantly lower than that reported during the pre-COVID-19 period (8.6% vs. 11.5%, p < 0.0001). Furthermore, the level of diagnostic certainty declined slightly across all outcomes investigated from the pre-COVID-19 to the intra-COVID-19 period. Nonetheless, diagnostic certainty was especially low for certain outcomes (i.e., stillbirth and NBSI) regardless of period; still, other outcomes, such as preterm birth and LBW, had moderate to high levels of diagnostic certainty. Results were mostly consistent when the analysis was focused on the facilities designated for COVID-19 care. Conclusion: This study succeeded in providing prevalence estimates for key adverse birth outcomes using GAIA criteria during the COVID-19 pandemic in Kinshasa, DRC. Furthermore, our study adds crucial real-world data to the literature surrounding the impact of the COVID-19 pandemic on maternal and neonatal services and outcomes in Africa.